Amanda Green
Psychiatric/Mental Health · Marietta, GANPI 1801151592
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.7% of the total across 239 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 28 manufacturers, the largest accounting for just 15.1% — the pattern of someone who eats at a lot of different presentations. Among psychiatric/mental health clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 239 payments — averaging $20.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$726
- AbbVie$553
- Otsuka America Pharmaceutical, Inc.$499
- Takeda Pharmaceuticals U.S.A., Inc.$419
- Johnson & Johnson$313
- Teva Pharmaceuticals USA, Inc.$226
- plus $2K from 22 others
What the payments were for
- Food & beverage$4,65797%
- Education$1583%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 35 | $726 |
| AbbVie | 31 | $553 |
| Otsuka America Pharmaceutical, Inc. | 27 | $499 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $419 |
| Johnson & Johnson(2 entities) | 14 | $313 |
| Teva Pharmaceuticals USA, Inc. | 7 | $226 |
| Lundbeck LLC | 11 | $222 |
| Abbott | 14 | $221 |
| Alkermes, Inc. | 8 | $198 |
| Axsome Therapeutics, Inc. | 6 | $169 |
| Corium, LLC | 8 | $166 |
| Neurocrine Biosciences, Inc. | 7 | $135 |
| Bausch Health US, LLC | 8 | $129 |
| Supernus Pharmaceuticals, Inc. | 7 | $126 |
| Neos Therapeutics, LP | 6 | $113 |
| Vanda Pharmaceuticals Inc. | 5 | $100 |
| Idorsia Pharmaceuticals US Inc | 4 | $85 |
| Ironshore Pharmaceuticals Inc. | 5 | $82 |
| Noven Therapeutics, LLC | 4 | $79 |
| Merck | 4 | $66 |
| Tris Pharma Inc | 2 | $36 |
| Adlon Therapeutics L.p. | 2 | $30 |
| Collegium Pharmaceutical, Inc. | 1 | $25 |
| Noven Pharmaceuticals, Inc. | 1 | $24 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Almatica Pharma LLC | 1 | $21 |
| OWP Pharmaceuticals, Inc. | 1 | $19 |
| Jazz Pharmaceuticals Inc. | 1 | $14 |
How this compares
$4,815 in reported general payments places this provider in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| IngrezzaValbenazine Tosylate | 12 | $102,474 |
| VraylarCariprazine Hcl | 18 | $24,624 |
| CaplytaLumateperone Tosylate | 13 | $24,548 |
| AuvelityDextromethorphan Hbr/Bupropion | 14 | $17,260 |
| Chlorpromazine Hcl | 49 | $6,974 |
| Clozapine | 51 | $3,801 |
| Lurasidone Hcl | 20 | $3,051 |
| Aripiprazole | 34 | $2,849 |
| Oxcarbazepine | 36 | $1,402 |
| Divalproex Sodium ErDivalproex Sodium | 25 | $1,245 |
| Benztropine Mesylate | 55 | $714 |
| Trazodone Hcl | 35 | $618 |
| Topiramate | 33 | $578 |
| Olanzapine | 25 | $575 |
| Risperidone | 61 | $547 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Neurocrine Biosciences, Inc.Ingrezza | $135 | $102,47412 claims |
| AbbVieVraylar | $553 | $24,62418 claims |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)Caplyta | $726 | $24,54813 claims |
| Axsome Therapeutics, Inc.Auvelity | $169 | $17,26014 claims |
| Almatica Pharma LLCSertraline Hcl | $21 | $19034 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in Marietta
- Namita PatelMarietta$8K
- Bunmi OgungbejeMarietta$6K
- Rebecca WhiteMarietta$5K
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.